1956
DOI: 10.1136/sti.32.4.236
|View full text |Cite
|
Sign up to set email alerts
|

Late Hepatic Syphilis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1997
1997
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…Liver biopsy for our patient was suggestive of mixed inflammation with patchy necrosis and negative for granulomas and spirochetes (Figure 2). Other cases reported granulomas and inflammatory cells in portal tracts and hepatic lobules [3][4][5][6][7][8]. Our case presented a patient with primarily dermatologic complaints whose evaluation led to the diagnosis of syphilitic hepatitis.…”
Section: Table 1: Comparison Of Patients Described In Referenced Case...mentioning
confidence: 81%
See 1 more Smart Citation
“…Liver biopsy for our patient was suggestive of mixed inflammation with patchy necrosis and negative for granulomas and spirochetes (Figure 2). Other cases reported granulomas and inflammatory cells in portal tracts and hepatic lobules [3][4][5][6][7][8]. Our case presented a patient with primarily dermatologic complaints whose evaluation led to the diagnosis of syphilitic hepatitis.…”
Section: Table 1: Comparison Of Patients Described In Referenced Case...mentioning
confidence: 81%
“…While hepatitis remains an uncommon manifestation of syphilis, hepatic involvement has been a known sequela since 1585, as described by Paracelsus [ 3 ]. Kellock and Laird noted in 1956 that the diagnosis was predominantly clinical and supported by positive serological evidence, response to treatment, and lack of evidence for alternate etiologies [ 5 ]. These early observations are reflected in the criteria outlined by Mullick et al in 2004 [ 3 ]: (1) abnormal liver function tests (LFTs); (2) positive syphilis serologies (RPR and fluorescent treponemal antibody absorption [FTA-Abs] or microhemagglutination assay for Treponema pallidum antibodies [MHA-TP]); (3) evidence to rule out other etiologies of hepatic injury and (4) clinical improvement of LFTs following initiation of pharmacologic therapy.…”
Section: Discussionmentioning
confidence: 99%